Coherus Oncology, Inc.CHRSNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
45.05%
↑ 260% above average
Average (9y)
-28.23%
Historical baseline
Range
High:152.72%
Low:-268.79%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 45.05% |
| 2023 | 20.90% |
| 2022 | 2.64% |
| 2021 | -268.79% |
| 2020 | 45.05% |
| 2019 | 152.72% |
| 2018 | 11.94% |
| 2017 | -100.24% |
| 2016 | 47.08% |
| 2015 | -238.68% |